Sasso Rick C, Smucker Joseph D, Hacker Robert J, Heller John G
Indiana Spine Group, Clinical Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, USA.
J Spinal Disord Tech. 2007 Oct;20(7):481-91. doi: 10.1097/BSD.0b013e3180310534.
STUDY DESIGN/SETTING: Prospective, randomized, 3-center, clinical trial.
To prospectively compare the outcomes of cervical arthroplasty with the BRYAN Cervical Disc Prosthesis (Medtronic Sofamor Danek, Inc, Memphis, TN) to anterior cervical discectomy and fusion (ACDF).
Surgical treatment of cervical disc pathology commonly involves techniques that employ discectomy and fusion (ACDF). This "gold-standard" technique has demonstrated good clinical and radiographic outcomes. Common adverse effects of this procedure are associated with the adjacent level degeneration and bone-graft harvest. Several investigators have independently reported successful short-term outcomes with the BRYAN Cervical Disc Prosthesis. In addition, a significant body of knowledge has been collected regarding the wear patterns and adjacent level effects of this device in human and animal models.
As part of an FDA IDE trial, 3 centers collected prospective outcomes data on 115 patients randomized in a 1:1 ratio to ACDF (Control group) or arthroplasty with the BRYAN Cervical Disc Prosthesis (Investigational group).
Demographic and surgical data were generally similar in the 2 populations. Outcomes data collected at routine postoperative intervals for 24 months demonstrated that the Investigational group had statistically significant (P<0.05) improvements as assessed by the Neck Disability Index, the Neck Pain Score, and SF-36 Physical component scores. The improvement in the Mental Component Subscore values for the BRYAN and control groups was equivalent at 24 months (P=0.055). Arm pain relief was similar in both groups (P=0.152). During the course of the 2-year follow-up, 4 patients in the Control group required surgical intervention and 3 patients in the Investigational group required ACDF for adjacent level disease.
At 24 months, cervical arthroplasty with the BRYAN Cervical Disc Prosthesis compares favorably with ACDF as defined by standard outcomes scores.
研究设计/背景:前瞻性、随机、三中心临床试验。
前瞻性比较采用BRYAN颈椎间盘假体(美敦力索法玛·丹尼克公司,田纳西州孟菲斯)行颈椎置换术与颈椎前路椎间盘切除融合术(ACDF)的疗效。
颈椎间盘病变的手术治疗通常采用椎间盘切除融合术(ACDF)。这种“金标准”技术已显示出良好的临床和影像学疗效。该手术常见的不良反应与相邻节段退变和取骨有关。几位研究者独立报告了使用BRYAN颈椎间盘假体取得的成功短期疗效。此外,关于该装置在人体和动物模型中的磨损模式及相邻节段影响,也已积累了大量知识。
作为美国食品药品监督管理局器械研究豁免试验的一部分,3个中心收集了115例患者的前瞻性疗效数据,这些患者按1:1比例随机分为ACDF组(对照组)或采用BRYAN颈椎间盘假体行置换术组(研究组)。
两组患者的人口统计学和手术数据总体相似。术后常规随访24个月收集的疗效数据表明,根据颈部功能障碍指数、颈部疼痛评分和SF - 36身体成分评分评估,研究组有统计学显著改善(P<0.05)。24个月时,BRYAN组和对照组的精神成分子评分改善程度相当(P = 0.055)。两组的手臂疼痛缓解情况相似(P = 0.152)。在2年随访期间,对照组有4例患者需要手术干预,研究组有3例患者因相邻节段疾病需要行ACDF。
在24个月时,采用BRYAN颈椎间盘假体行颈椎置换术与ACDF相比,根据标准疗效评分结果显示效果良好。